Record mula sa primary source
MateryalPagbabago sa trial registry
sirolimus · NCT05103358 update ng registry
katayuan: ACTIVE_NOT_RECRUITING → COMPLETED; primary_completion: 2024-12-31 → 2024-12-23; completion: 2025-12-31 → 2024-12-23; enrollment: 120 → 128; primary_outcomes: ['Overall response rate (ORR)'] → ['Overall Response Rate (ORR)']
Mahahalagang fact
- Na-file
- Set 28, 2026, 03:22 PM
- Kaganapan
- Pagbabago sa trial registry
- Direksyon
- Neutral
- Kumpanya
OBIOOrchestra BioMed- Asset
- sirolimus
- Pinagmulan
- ClinicalTrials.gov
- Kumpiyansa
- May source
Higit pa tungkol sa asset na ito
Okt 28, 2025
12:12 PM
OBIOOrchestra BioMedPumasok ang Orchestra BioMed sa $30M Terumo ROFR at kasunduan sa pamumuhunan para sa Virtue SAB